questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzazépines
Benzazépines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dépendance aux médicaments
Benzodiazépines
Tests de dépistage
Benzodiazépines
Trouble d'usage de substances
Benzodiazépines
Effets secondaires
Benzodiazépines
Symptômes
5
Symptômes
Benzodiazépines
Effets à long terme
Benzodiazépines
Troubles de la mémoire
Benzodiazépines
Prévention
5
Prévention
Dépendance aux médicaments
Recommandations
Benzodiazépines
Éducation des patients
Benzodiazépines
Auto-médication
Benzodiazépines
Réduction de l'usage
Benzodiazépines
Traitements
5
Prescription
Benzodiazépines
Suivi médical
Benzodiazépines
Complications
5
Complications
Benzodiazépines
Dépression respiratoire
Benzodiazépines
Interactions médicamenteuses
Benzodiazépines
Grossesse
Benzodiazépines
Facteurs de risque
5
Dépendance
Benzodiazépines
Personnes âgées
Benzodiazépines
Usage prolongé
Benzodiazépines
Facteurs psychologiques
Benzodiazépines
Interactions médicamenteuses
Benzodiazépines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzazépines : Questions médicales les plus fréquentes",
"headline": "Benzazépines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzazépines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-14",
"dateModified": "2025-05-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzazépines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzodiazépines",
"alternateName": "Benzodiazepines",
"url": "https://questionsmedicales.fr/mesh/D001569",
"about": {
"@type": "MedicalCondition",
"name": "Benzodiazépines",
"code": {
"@type": "MedicalCode",
"code": "D001569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alprazolam",
"alternateName": "Alprazolam",
"url": "https://questionsmedicales.fr/mesh/D000525",
"about": {
"@type": "MedicalCondition",
"name": "Alprazolam",
"code": {
"@type": "MedicalCode",
"code": "D000525",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Benzodiazépinones",
"alternateName": "Benzodiazepinones",
"url": "https://questionsmedicales.fr/mesh/D001570",
"about": {
"@type": "MedicalCondition",
"name": "Benzodiazépinones",
"code": {
"@type": "MedicalCode",
"code": "D001570",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromazépam",
"alternateName": "Bromazepam",
"url": "https://questionsmedicales.fr/mesh/D001960",
"about": {
"@type": "MedicalCondition",
"name": "Bromazépam",
"code": {
"@type": "MedicalCode",
"code": "D001960",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clonazépam",
"alternateName": "Clonazepam",
"url": "https://questionsmedicales.fr/mesh/D002998",
"about": {
"@type": "MedicalCondition",
"name": "Clonazépam",
"code": {
"@type": "MedicalCode",
"code": "D002998",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dévazépide",
"alternateName": "Devazepide",
"url": "https://questionsmedicales.fr/mesh/D020109",
"about": {
"@type": "MedicalCondition",
"name": "Dévazépide",
"code": {
"@type": "MedicalCode",
"code": "D020109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diazépam",
"alternateName": "Diazepam",
"url": "https://questionsmedicales.fr/mesh/D003975",
"about": {
"@type": "MedicalCondition",
"name": "Diazépam",
"code": {
"@type": "MedicalCode",
"code": "D003975",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flumazénil",
"alternateName": "Flumazenil",
"url": "https://questionsmedicales.fr/mesh/D005442",
"about": {
"@type": "MedicalCondition",
"name": "Flumazénil",
"code": {
"@type": "MedicalCode",
"code": "D005442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.305"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flunitrazépam",
"alternateName": "Flunitrazepam",
"url": "https://questionsmedicales.fr/mesh/D005445",
"about": {
"@type": "MedicalCondition",
"name": "Flunitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D005445",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flurazépam",
"alternateName": "Flurazepam",
"url": "https://questionsmedicales.fr/mesh/D005479",
"about": {
"@type": "MedicalCondition",
"name": "Flurazépam",
"code": {
"@type": "MedicalCode",
"code": "D005479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.348"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lorazépam",
"alternateName": "Lorazepam",
"url": "https://questionsmedicales.fr/mesh/D008140",
"about": {
"@type": "MedicalCondition",
"name": "Lorazépam",
"code": {
"@type": "MedicalCode",
"code": "D008140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrazépam",
"alternateName": "Nitrazepam",
"url": "https://questionsmedicales.fr/mesh/D009567",
"about": {
"@type": "MedicalCondition",
"name": "Nitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D009567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.565"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxazépam",
"alternateName": "Oxazepam",
"url": "https://questionsmedicales.fr/mesh/D010076",
"about": {
"@type": "MedicalCondition",
"name": "Oxazépam",
"code": {
"@type": "MedicalCode",
"code": "D010076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.663"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pirenzépine",
"alternateName": "Pirenzepine",
"url": "https://questionsmedicales.fr/mesh/D010890",
"about": {
"@type": "MedicalCondition",
"name": "Pirenzépine",
"code": {
"@type": "MedicalCode",
"code": "D010890",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prazépam",
"alternateName": "Prazepam",
"url": "https://questionsmedicales.fr/mesh/D011222",
"about": {
"@type": "MedicalCondition",
"name": "Prazépam",
"code": {
"@type": "MedicalCode",
"code": "D011222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.784"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Témazépam",
"alternateName": "Temazepam",
"url": "https://questionsmedicales.fr/mesh/D013693",
"about": {
"@type": "MedicalCondition",
"name": "Témazépam",
"code": {
"@type": "MedicalCode",
"code": "D013693",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.880"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Bromazépam",
"alternateName": "Bromazepam",
"url": "https://questionsmedicales.fr/mesh/D001960",
"about": {
"@type": "MedicalCondition",
"name": "Bromazépam",
"code": {
"@type": "MedicalCode",
"code": "D001960",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clonazépam",
"alternateName": "Clonazepam",
"url": "https://questionsmedicales.fr/mesh/D002998",
"about": {
"@type": "MedicalCondition",
"name": "Clonazépam",
"code": {
"@type": "MedicalCode",
"code": "D002998",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dévazépide",
"alternateName": "Devazepide",
"url": "https://questionsmedicales.fr/mesh/D020109",
"about": {
"@type": "MedicalCondition",
"name": "Dévazépide",
"code": {
"@type": "MedicalCode",
"code": "D020109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diazépam",
"alternateName": "Diazepam",
"url": "https://questionsmedicales.fr/mesh/D003975",
"about": {
"@type": "MedicalCondition",
"name": "Diazépam",
"code": {
"@type": "MedicalCode",
"code": "D003975",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flumazénil",
"alternateName": "Flumazenil",
"url": "https://questionsmedicales.fr/mesh/D005442",
"about": {
"@type": "MedicalCondition",
"name": "Flumazénil",
"code": {
"@type": "MedicalCode",
"code": "D005442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.305"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flunitrazépam",
"alternateName": "Flunitrazepam",
"url": "https://questionsmedicales.fr/mesh/D005445",
"about": {
"@type": "MedicalCondition",
"name": "Flunitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D005445",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flurazépam",
"alternateName": "Flurazepam",
"url": "https://questionsmedicales.fr/mesh/D005479",
"about": {
"@type": "MedicalCondition",
"name": "Flurazépam",
"code": {
"@type": "MedicalCode",
"code": "D005479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.348"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lorazépam",
"alternateName": "Lorazepam",
"url": "https://questionsmedicales.fr/mesh/D008140",
"about": {
"@type": "MedicalCondition",
"name": "Lorazépam",
"code": {
"@type": "MedicalCode",
"code": "D008140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrazépam",
"alternateName": "Nitrazepam",
"url": "https://questionsmedicales.fr/mesh/D009567",
"about": {
"@type": "MedicalCondition",
"name": "Nitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D009567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.565"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxazépam",
"alternateName": "Oxazepam",
"url": "https://questionsmedicales.fr/mesh/D010076",
"about": {
"@type": "MedicalCondition",
"name": "Oxazépam",
"code": {
"@type": "MedicalCode",
"code": "D010076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.663"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pirenzépine",
"alternateName": "Pirenzepine",
"url": "https://questionsmedicales.fr/mesh/D010890",
"about": {
"@type": "MedicalCondition",
"name": "Pirenzépine",
"code": {
"@type": "MedicalCode",
"code": "D010890",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prazépam",
"alternateName": "Prazepam",
"url": "https://questionsmedicales.fr/mesh/D011222",
"about": {
"@type": "MedicalCondition",
"name": "Prazépam",
"code": {
"@type": "MedicalCode",
"code": "D011222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.784"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Témazépam",
"alternateName": "Temazepam",
"url": "https://questionsmedicales.fr/mesh/D013693",
"about": {
"@type": "MedicalCondition",
"name": "Témazépam",
"code": {
"@type": "MedicalCode",
"code": "D013693",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.880"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlordiazépoxyde",
"alternateName": "Chlordiazepoxide",
"url": "https://questionsmedicales.fr/mesh/D002707",
"about": {
"@type": "MedicalCondition",
"name": "Chlordiazépoxyde",
"code": {
"@type": "MedicalCode",
"code": "D002707",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clobazam",
"alternateName": "Clobazam",
"url": "https://questionsmedicales.fr/mesh/D000078306",
"about": {
"@type": "MedicalCondition",
"name": "Clobazam",
"code": {
"@type": "MedicalCode",
"code": "D000078306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.165"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clorazépate dipotassique",
"alternateName": "Clorazepate Dipotassium",
"url": "https://questionsmedicales.fr/mesh/D003009",
"about": {
"@type": "MedicalCondition",
"name": "Clorazépate dipotassique",
"code": {
"@type": "MedicalCode",
"code": "D003009",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.180"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Estazolam",
"alternateName": "Estazolam",
"url": "https://questionsmedicales.fr/mesh/D004949",
"about": {
"@type": "MedicalCondition",
"name": "Estazolam",
"code": {
"@type": "MedicalCode",
"code": "D004949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Médazépam",
"alternateName": "Medazepam",
"url": "https://questionsmedicales.fr/mesh/D008472",
"about": {
"@type": "MedicalCondition",
"name": "Médazépam",
"code": {
"@type": "MedicalCode",
"code": "D008472",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Midazolam",
"alternateName": "Midazolam",
"url": "https://questionsmedicales.fr/mesh/D008874",
"about": {
"@type": "MedicalCondition",
"name": "Midazolam",
"code": {
"@type": "MedicalCode",
"code": "D008874",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Olanzapine",
"alternateName": "Olanzapine",
"url": "https://questionsmedicales.fr/mesh/D000077152",
"about": {
"@type": "MedicalCondition",
"name": "Olanzapine",
"code": {
"@type": "MedicalCode",
"code": "D000077152",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.738"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Triazolam",
"alternateName": "Triazolam",
"url": "https://questionsmedicales.fr/mesh/D014229",
"about": {
"@type": "MedicalCondition",
"name": "Triazolam",
"code": {
"@type": "MedicalCode",
"code": "D014229",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.900"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Diltiazem",
"alternateName": "Diltiazem",
"url": "https://questionsmedicales.fr/mesh/D004110",
"about": {
"@type": "MedicalCondition",
"name": "Diltiazem",
"code": {
"@type": "MedicalCode",
"code": "D004110",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fénoldopam",
"alternateName": "Fenoldopam",
"url": "https://questionsmedicales.fr/mesh/D018818",
"about": {
"@type": "MedicalCondition",
"name": "Fénoldopam",
"code": {
"@type": "MedicalCode",
"code": "D018818",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Galantamine",
"alternateName": "Galantamine",
"url": "https://questionsmedicales.fr/mesh/D005702",
"about": {
"@type": "MedicalCondition",
"name": "Galantamine",
"code": {
"@type": "MedicalCode",
"code": "D005702",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.525"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ivabradine",
"alternateName": "Ivabradine",
"url": "https://questionsmedicales.fr/mesh/D000077550",
"about": {
"@type": "MedicalCondition",
"name": "Ivabradine",
"code": {
"@type": "MedicalCode",
"code": "D000077550",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.801"
}
}
},
{
"@type": "MedicalWebPage",
"name": "1-Phényl-2,3,4,5-tétrahydro-1H-3-benzazépine-7,8-diol",
"alternateName": "2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",
"url": "https://questionsmedicales.fr/mesh/D015647",
"about": {
"@type": "MedicalCondition",
"name": "1-Phényl-2,3,4,5-tétrahydro-1H-3-benzazépine-7,8-diol",
"code": {
"@type": "MedicalCode",
"code": "D015647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.838"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tolvaptan",
"alternateName": "Tolvaptan",
"url": "https://questionsmedicales.fr/mesh/D000077602",
"about": {
"@type": "MedicalCondition",
"name": "Tolvaptan",
"code": {
"@type": "MedicalCode",
"code": "D000077602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzazépines",
"alternateName": "Benzazepines",
"code": {
"@type": "MedicalCode",
"code": "D001552",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Bernhard Wünsch",
"url": "https://questionsmedicales.fr/author/Bernhard%20W%C3%BCnsch",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany."
}
},
{
"@type": "Person",
"name": "Dirk Schepmann",
"url": "https://questionsmedicales.fr/author/Dirk%20Schepmann",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, 48149, Münster, Germany."
}
},
{
"@type": "Person",
"name": "Simon M Ametamey",
"url": "https://questionsmedicales.fr/author/Simon%20M%20Ametamey",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland simon.ametamey@pharma.ethz.ch."
}
},
{
"@type": "Person",
"name": "Nadine Ritter",
"url": "https://questionsmedicales.fr/author/Nadine%20Ritter",
"affiliation": {
"@type": "Organization",
"name": "Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany. nadine.ritter@uni-muenster.de."
}
},
{
"@type": "Person",
"name": "Guiscard Seebohm",
"url": "https://questionsmedicales.fr/author/Guiscard%20Seebohm",
"affiliation": {
"@type": "Organization",
"name": "Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern U.S.",
"datePublished": "2022-10-08",
"url": "https://questionsmedicales.fr/article/36209179",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10461-022-03883-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "HIV Pre-Exposure Prophylaxis in the Emergency Department: A Systematic Review.",
"datePublished": "2022-09-15",
"url": "https://questionsmedicales.fr/article/36117011",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.annemergmed.2022.07.015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interrogating the promise of long-acting HIV pre-exposure prophylaxis.",
"datePublished": "2022-11-23",
"url": "https://questionsmedicales.fr/article/36435632",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.molmed.2022.11.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Residents and Fellows’ Confidence in Prescribing Pre-exposure Prophylaxis (PrEP)",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36893907",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.acap.2023.02.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Users' expectations of the new pre-exposure prophylaxis for the HIV modalities.",
"datePublished": "2023-08-30",
"url": "https://questionsmedicales.fr/article/38896667",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1413-81232024296.03042023"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzazépines",
"item": "https://questionsmedicales.fr/mesh/D001552"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzazépines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzazépines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzazépines",
"description": "Comment diagnostiquer une dépendance aux benzazépines ?\nQuels tests sont utilisés pour évaluer l'usage des benzazépines ?\nQuels critères DSM sont liés aux benzazépines ?\nComment évaluer les effets secondaires des benzazépines ?\nQuels signes indiquent une surdose de benzazépines ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Pre-Exposure+Prophylaxis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzazépines",
"description": "Quels sont les symptômes d'une surconsommation de benzazépines ?\nComment se manifeste le sevrage des benzazépines ?\nQuels effets à long terme des benzazépines ?\nQuels symptômes d'anxiété peuvent être soulagés par les benzazépines ?\nLes benzazépines causent-elles des troubles de la mémoire ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Pre-Exposure+Prophylaxis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzazépines",
"description": "Comment prévenir la dépendance aux benzazépines ?\nQuelles sont les recommandations pour l'utilisation des benzazépines ?\nComment éduquer les patients sur les benzazépines ?\nQuels sont les risques d'auto-médication avec des benzazépines ?\nComment réduire l'usage des benzazépines dans la population ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Pre-Exposure+Prophylaxis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzazépines",
"description": "Comment sont prescrites les benzazépines ?\nQuelles alternatives aux benzazépines pour l'anxiété ?\nComment gérer une overdose de benzazépines ?\nLes benzazépines sont-elles efficaces pour l'insomnie ?\nQuel suivi est nécessaire lors de l'utilisation de benzazépines ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Pre-Exposure+Prophylaxis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzazépines",
"description": "Quelles complications peuvent survenir avec les benzazépines ?\nLes benzazépines augmentent-elles le risque de chutes ?\nComment les benzazépines affectent-elles la respiration ?\nLes benzazépines peuvent-elles interagir avec d'autres médicaments ?\nQuels sont les effets des benzazépines sur la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Pre-Exposure+Prophylaxis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzazépines",
"description": "Quels facteurs augmentent le risque de dépendance aux benzazépines ?\nLes personnes âgées sont-elles plus à risque avec les benzazépines ?\nComment l'usage prolongé de benzazépines affecte-t-il le risque ?\nQuels facteurs psychologiques influencent l'usage des benzazépines ?\nLes interactions médicamenteuses augmentent-elles les risques ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Pre-Exposure+Prophylaxis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance aux benzazépines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'utilisation, les symptômes de sevrage et les comportements compulsifs."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'usage des benzazépines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage de drogues et des évaluations psychologiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont liés aux benzazépines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères DSM-5 pour le trouble d'usage de substances s'appliquent aux benzazépines."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets secondaires des benzazépines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'observation des symptômes et l'historique médical du patient."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose de benzazépines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, somnolence excessive, et dépression respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surconsommation de benzazépines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent somnolence, confusion, et troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le sevrage des benzazépines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage peut provoquer anxiété, insomnie, tremblements et convulsions."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des benzazépines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des troubles cognitifs et une dépendance."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'anxiété peuvent être soulagés par les benzazépines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les benzazépines soulagent l'anxiété, les crises de panique et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les benzazépines causent-elles des troubles de la mémoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles de la mémoire, surtout à forte dose."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dépendance aux benzazépines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter la durée de prescription et surveiller l'utilisation sont des mesures préventives."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour l'utilisation des benzazépines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser à la dose minimale efficace et pour la durée la plus courte possible."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les benzazépines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les risques, les effets secondaires et l'importance du suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'auto-médication avec des benzazépines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'auto-médication peut entraîner des surdoses, des dépendances et des interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Comment réduire l'usage des benzazépines dans la population ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Promouvoir des alternatives thérapeutiques et sensibiliser aux risques associés."
}
},
{
"@type": "Question",
"name": "Comment sont prescrites les benzazépines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont prescrites pour des périodes courtes, généralement moins de 4 semaines."
}
},
{
"@type": "Question",
"name": "Quelles alternatives aux benzazépines pour l'anxiété ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs, thérapies cognitives et techniques de relaxation sont des alternatives."
}
},
{
"@type": "Question",
"name": "Comment gérer une overdose de benzazépines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'overdose nécessite une attention médicale immédiate, souvent avec des antidotes comme le flumazénil."
}
},
{
"@type": "Question",
"name": "Les benzazépines sont-elles efficaces pour l'insomnie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont efficaces à court terme, mais peuvent entraîner une dépendance et des effets secondaires."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire lors de l'utilisation de benzazépines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est essentiel pour évaluer l'efficacité et surveiller les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les benzazépines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dépendance, les troubles cognitifs et les accidents liés à la somnolence."
}
},
{
"@type": "Question",
"name": "Les benzazépines augmentent-elles le risque de chutes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent le risque de chutes, surtout chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Comment les benzazépines affectent-elles la respiration ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent déprimer le système respiratoire, surtout en cas de surdose."
}
},
{
"@type": "Question",
"name": "Les benzazépines peuvent-elles interagir avec d'autres médicaments ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent interagir avec des opioïdes, des antidépresseurs et d'autres sédatifs."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des benzazépines sur la grossesse ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent causer des malformations congénitales et des complications néonatales."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dépendance aux benzazépines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles de l'usage de substances et les troubles mentaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque avec les benzazépines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus sensibles aux effets sédatifs et aux risques de chutes."
}
},
{
"@type": "Question",
"name": "Comment l'usage prolongé de benzazépines affecte-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage prolongé augmente le risque de dépendance et de troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels facteurs psychologiques influencent l'usage des benzazépines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété, la dépression et le stress peuvent inciter à l'usage des benzazépines."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses augmentent-elles les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent intensifier les effets sédatifs et augmenter le risque d'accidents."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/05/2025
Contenu vérifié selon les dernières recommandations médicales
9 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany.
7 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, 48149, Münster, Germany.
5 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland simon.ametamey@pharma.ethz.ch.
Publications dans "Benzazépines" :
3 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany. nadine.ritter@uni-muenster.de.
Chembion, University of Münster, 48149, Münster, Germany. nadine.ritter@uni-muenster.de.
Publications dans "Benzazépines" :
3 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Chembion, University of Münster, 48149, Münster, Germany.
Publications dans "Benzazépines" :
3 publications dans cette catégorie
Affiliations :
Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Chembion, University of Münster, 48149, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, 48149, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan. Electronic address: arai.yoshikazu.mh@daiichisankyo.co.jp.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.
Publications dans "Benzazépines" :
Despite efficacy in HIV prevention, Pre-exposure Prophylaxis (PrEP) is underutilized in the US, especially among populations at highest risk. PrEP-related stigma may play a role. We developed measures...
Many emergency departments (EDs) have identified the importance of HIV prevention and have implemented steps to screen and offer preexposure prophylaxis (PrEP). The objective of this study was to syst...
Four databases captured all PrEP-related studies in EDs from January 1, 2013 to January 27, 2022. Data were extracted on study characteristics and outcomes, and study quality was assessed using a modi...
Of the 218 articles, 16 were subjected to full-text review, and 7 met inclusion criteria. Although most studies identified patients who were PrEP eligible using criteria adapted from the 2017 Centers ...
Although up to a third of patients in ED assessed in the current study were PrEP eligible, less than half of PrEP-eligible participants had prior knowledge of PrEP, and very few who expressed interest...
Oral HIV pre-exposure prophylaxis (PrEP) is a well-established product that provides a safe and highly effective way for individuals to protect themselves against HIV infection. However, hopes of a si...
Residents and fellows are often the first health.ßcare providers to discuss sexual health and prevention with adolescents and young adults at academic institutions. This study characterized when learn...
Learners at a large, urban, southern academic center completed an online survey about adolescent sexual health services. Measures included whether participants were taught how to prescribe PrEP and ho...
Among the 228 respondents (63% response rate), most learners preferred sexual health communication to be emphasized early in medical school and throughout training. Overall, 44% reported being ..únot ...
Given the continued high rates of new human immunodeficiency virus infections among adolescents, effective communication with patients eligible for PrEP is critical. Future studies should evaluate and...
This article aims to discuss the expectations of Homosexual Men, Bisexual Men and a Transgender Woman, who use or want to use an oral pre-exposure prophylaxis (PrEP) for the human immunodeficiency vir...
An effective clinical decision support system (CDSS) may address the current provider training barrier to offering preexposure prophylaxis (PrEP) to youth at risk for human immunodeficiency virus (HIV...
This was a prospective study using survey responses from a convenience sample of pediatric providers who launched the interruptive PrEP CDSS when ordering an HIV test. McNemar's test evaluated change ...
Of the 73 invited providers, 43 had available outcome data and were included in the analysis. Prior to using the CDSS, 86% of participants had never been prescribed PrEP. Compared to before CDSS expos...
Our findings suggest that an interruptive PrEP CDSS attached to HIV test orders can be an effective tool to increase knowledge and likelihood to initiate PrEP among pediatric providers. Continual impr...
to identify and synthesize scientific evidence on the barriers and difficulties for Pre-exposure Prophylaxis (PrEP) use and compliance for HIV....
an integrative literature review, using the MEDLINE/PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Academic Search Premier and Scopus (Elsevier) databases....
all (100%) the articles included identified that PrEP users experience some type of structural barrier related to health services such as long distance from the units, suboptimal logistics for taking ...
the barriers to PrEP use are multifactorial. Effective interventions are needed to support PrEP users in accessing, complying with, and retaining health services....
To date, there are no established scales to assess PrEP stigma among youth. We validated the Youth PrEP Stigma Scale within the Adolescent Trials Network P3 study (2019-2021). Data from sexual and gen...
It is estimated that 450,000 American women are at increased risk of infection with human immunodeficiency virus (HIV), and yet only 7% have a prescription for pre-exposure prophylaxis (PrEP). PrEP is...
Testing guidelines for initiation of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) have been developed to ensure appropriate use of PrEP, such as among those with renal dysfun...